Financial News
Xeris Pharmaceuticals Inc (NQ: XERS )
2.880
+0.080
(+2.86%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Xeris Pharmaceuticals Inc
![](https://mms.businesswire.com/media/20240822640280/en/2221707/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
Xeris to Participate in Upcoming Investor Conferences
August 22, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240808523637/en/2210223/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
Xeris Biopharma Reports Second Quarter 2024 Financial Results
August 08, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240725635772/en/2183641/22/xeris_BIOPHARMA_TM_L_CMYK_002.jpg)
![](https://mms.businesswire.com/media/20240708688946/en/2178838/22/xeris_BIOPHARMA_TM_L_CMYK.jpg)
Xeris Biopharma Announces CEO Succession Plan
July 08, 2024
Via Business Wire
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20240703480900/en/2175482/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240603311134/en/2147784/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240530612890/en/2145175/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240530275222/en/2143504/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240509287355/en/2125539/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240506079856/en/2119832/5/Beta_Bionics_Logo_-_2Color.jpg)
![](https://mms.businesswire.com/media/20240502061352/en/2110350/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240403328919/en/2086848/22/xeris_BIOPHARMA_TM_L_CMYK_002.jpg)
![](https://mms.businesswire.com/media/20240402611352/en/2085318/22/xeris_BIOPHARMA_TM_L.jpg)
![](https://mms.businesswire.com/media/20240306129214/en/2055782/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240306343645/en/2055767/22/xeris_BIOPHARMA_TM_L_CMYK_002.jpg)
![](https://mms.businesswire.com/media/20240228184972/en/2046125/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240205852546/en/2021290/22/xeris_BIOPHARMA_TM_L.jpg)
![](https://mms.businesswire.com/media/20240109335095/en/1994963/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240105200069/en/1988826/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240104585894/en/1987301/22/xeris_BIOPHARMA_TM_L_CMYK.jpg)
Xeris Biopharma Updates Its Outlook for 2023
January 04, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20231227139846/en/1980463/22/xeris_BIOPHARMA_TM_L_CMYK.jpg)
![](https://mms.businesswire.com/media/20231109523978/en/1940337/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
Xeris Biopharma Reports Third Quarter 2023 Financial Results
November 09, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20231016784672/en/1914394/22/xeris_BIOPHARMA_TM_L_CMYK_002.jpg)
![](https://mms.businesswire.com/media/20230927968185/en/1900518/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
Xeris Biopharma Announces Private Convertible Note Exchange Transactions
September 27, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230914198760/en/1890542/22/xeris_BIOPHARMA_TM_L.jpg)
Xeris to Participate in the 2023 Cantor Global Healthcare Conference
September 14, 2023
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Xeris Biopharma Reports Second Quarter 2023 Financial Results
August 08, 2023
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.